Cited by 103Electrolyte and hormonal disordersCerebrospinal fluid and hydrocephalusNeuroendocrine regulation and behavior

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Cerebrospinal-fluid vasopressin in neurological and psychiatric-disorders

Open access

Sorensen, P S, Gjerris, A, Hammer, M·1985·Journal of Neurology, Neurosurgery & Psychiatry

DOI 10.1136/jnnp.48.1.50PMC PMC1028182

Open this paper in CoChat — free account Open PDF

Abstract

Vasopressin was determined in CSF and plasma of 243 patients with different neurological and psychiatric disorders, including control patients. CSF vasopressin was significantly higher in patients with high pressure hydrocephalus, intracranial tumour, benign intracranial hypertension, intracranial haemorrhage, ischaemic stroke, and craniocerebral trauma. In patients with primary degenerative dementia, CSF vasopressin was lower than in control patients. Among patients with psychiatric disorders, CSF vasopressin was increased in manic patients, while in patients with depression CSF concentration of this hormone did not differ from that found in controls. However, an increase in CSF vasopressin level was found in patients recovering from a depression. The clinical significance of changes in CSF vasopressin concentrations in groups of patients with neurological and psychiatric disorders is still unknown.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/jnnp.48.1.50

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS
Schumacher, G. A., Beebe, G., Kibler, R. F., Kurland, L. T., Kurtzke, J. F., McDowell, F., Nagler, B., Sibley, W. A., Tourtellotte, W. W., & Willmon, T. L. (1965) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb20235.x · Cited by 1,438
Intra- and extrahypothalamic vasopressin and oxytocin pathways in the rat
Buijs, R. M., Swaab, D. F., Dogterom, J., & van Leeuwen, F. W. (1978) · Cell and Tissue Research · doi:10.1007/bf00224932 · Cited by 1,029
The Bech‐Rafaelsen Mania Scale and the Hamilton Depression Scale
Bech, P., Bolwig, T. G., Kramp, P., & Rafaelsen, O. J. (1979) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1979.tb04484.x · Cited by 405
The influence of the posterior and inter-mediate lobe of the pituitary and pituitary peptides on the maintenance of a conditioned avoidance response in rats
Wled, D. D. (1965) · International Journal of Neuropharmacology · doi:10.1016/0028-3908(65)90005-5 · Cited by 377
COMPARISON OF WEIGHT REDUCTION WITH METOPROLOL IN TREATMENT OF HYPERTENSION IN YOUNG OVERWEIGHT PATIENTS
MacMahon, S. W., Bernstein, L., Macdonald, G., Andrews, G., & Blacket, R. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92310-4 · Cited by 365
Effects of Vasopressin on Human Memory Functions
Weingartner, H., Gold, P. W., Ballenger, J. C., Smallberg, S. A., Summers, R. L., Rubinow, D. R., Post, R. M., & Goodwin, F. K. (1981) · Science · doi:10.1126/science.7455701 · Cited by 315
INFLUENCE OF VASOPRESSIN ON LEARNING AND MEMORY
Legros, J.-J., Gilot, P., Seron, X., Claessens, J., Adam, A. A., Moeglen, J. M., Audibert, A., & Berchier, P. (1978) · The Lancet · doi:10.1016/s0140-6736(78)90386-0 · Cited by 220
Regulation of brain water permeability by centrally-released vasopressin
Raichle, M. E., & Grubb, R. L. (1978) · Brain Research · doi:10.1016/0006-8993(78)90766-7 · Cited by 212
The use of rating scales exemplified by a comparison of the Hamilton and the Bech‐Rafaelsen Melancholia Scale
Bech, P., & Rafaelsen, O. J. (1980) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1980.tb07683.x · Cited by 171
Vasopressin and Memory Consolidation
de Wied, D., Greidanus, T. B. V. W., Bohus, B., Urban, I. J. A., & Gispen, W. H. (1976) · Progress in brain research · doi:10.1016/s0079-6123(08)60990-5 · Cited by 166

Flagged first, then by citations

Show all 46 references

Research works printed but not linked: 2

Brownfield MS, Kozlowski GP. The hyothalamochoroidal tract. I. Immunohistochemical demonstration of neurophysin pathways to telencephalic choroid plexuses and cerebrospinal fluid. Cell Tissue Res 1977; 178:111-27.
Sorensen PS, Vilhardt H, Gjerris F, Warberg J. Impermeability of the blood-cerebrospinal fluid barrier to l-deamino-8-D-arginine-vasopressin (DDAVP) in man. Eur J Clin Invest (In press).

Sorted by citations

Cerebrospinal Fluid Vasopressin Levels
Coccaro, E. F., Kavoussi, R. J., Hauger, R. L., Cooper, T. B., & Ferris, C. F. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.8.708 · Cited by 392
Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study
Loup, F., Tribollet, E., Dubois-Dauphin, M., & Dreifuss, J. J. (1991) · Brain Research · doi:10.1016/0006-8993(91)90345-v · Cited by 378
Plasma Levels of Arginine Vasopressin Elevated in Patients with Major Depression
van Londen, L. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00054-7 · Cited by 306
Mechanisms of Altered Water Metabolism in Psychotic Patients with Polydipsia and Hyponatremia
Goldman, M. B., Luchins, D. J., & Robertson, G. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198802183180702 · Cited by 295
Bumetanide Inhibition of the Blood-Brain Barrier Na-K-Cl Cotransporter Reduces Edema Formation in the Rat Middle Cerebral Artery Occlusion Model of Stroke
O’Donnell, M. E., Tran, L., Lam, T. I., Liu, X. B., & Anderson, S. E. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000130867.32663.90 · Cited by 250
Elevated Cerebrospinal Fluid Levels of Oxytocin in Obsessive-compulsive Disorder: Comparison With Tourette's Syndrome and Healthy Controls
Leckman, J. F. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950100030003 · Cited by 209
Abnormalities in the Regulation of Vasopressin and Corticotropin Releasing Factor Secretion in Obsessive-Compulsive Disorder
Altemus, M. M. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820010009002 · Cited by 187
Oxytocin and vasopressin effects on the neural response to social cooperation are modulated by sex in humans
Feng, C., Hackett, P. D., DeMarco, A. C., Chen, X., Stair, S., Haroon, E., Ditzen, B., Pagnoni, G., & Rilling, J. K. (2015) · Brain Imaging and Behavior · doi:10.1007/s11682-014-9333-9 · Cited by 157
Innovative Approaches for the Treatment of Depression: Targeting the HPA Axis
THOMSON, F. J., & Craighead, M. W. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9518-3 · Cited by 158
Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis
Rutigliano, G., Rocchetti, M., Paloyelis, Y., Gilleen, J., Sardella, A., Cappucciati, M., Palombini, E., Dell’Osso, L., Caverzasi, E., Politi, P., et al. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.04.117 · Cited by 149
“Plasma oxytocin levels in autistic children.”
Influential
The Central Vasopressinergic System: Examining the Opportunities for Psychiatric Drug Development
Ring, R. H. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053382241 · Cited by 142
Cerebral microvascular endothelial cell Na/H exchange: evidence for the presence of NHE1 and NHE2 isoforms and regulation by arginine vasopressin
Lam, T. I., Wise, P. M., & O’Donnell, M. E. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00093.2009 · Cited by 78
Vasopressin Amplifies the Production of Proinflammatory Mediators in Traumatic Brain Injury
Szmydynger‐Chodobska, J., Fox, L. M., Lynch, K. M., Zink, B. J., & Chodobski, A. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2010.1331 · Cited by 77
Blood–Brain Barrier Na Transporters in Ischemic Stroke
O’Donnell, M. E. (2014) · Advances in pharmacology · doi:10.1016/bs.apha.2014.06.011 · Cited by 78
Arginine vasopressin stimulation of cerebral microvascular endothelial cell Na-K-Cl cotransporter activity is V1 receptor and [Ca] dependent
O’Donnell, M. E., Duong, V., Suvatne, J., Foroutan, S., & Johnson, D. M. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00001.2005 · Cited by 73
Bumetanide Reduces Cerebral Edema Formation in Rats With Diabetic Ketoacidosis
Lam, T. I., Anderson, S. E., Glaser, N. S., & O’Donnell, M. E. (2005) · Diabetes · doi:10.2337/diabetes.54.2.510 · Cited by 71
Attenuated Development of Ischemic Brain Edema in Vasopressin-Deficient Rats
Dickinson, L. D., & Betz, A. L. (1992) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1992.93 · Cited by 70
Cerebrospinal Fluid Vasopressin—Changes in Depression
Gjerris, A., Vendsborg, P. B., HAMMER, M., Christensen, N. J., & Rafaelsen, O. J. (1985) · The British Journal of Psychiatry · doi:10.1192/bjp.147.6.696 · Cited by 69
Self-citation
Selective vasopressin-1a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and GFAP, V1aR and AQP4 expression after focal traumatic brain injury
Marmarou, C. R., Liang, X., Abidi, N. H., Parveen, S., Taya, K., Henderson, S. C., Young, H. F., Filippidis, A., & Baumgarten, C. M. (2014) · Brain Research · doi:10.1016/j.brainres.2014.06.005 · Cited by 64
No vasopressin cell loss in the human hypothalamus in aging and Alzheimer's disease
Woude, P. F. V. D., Goudsmit, E., Wierda, M., Purba, J. S., Hofman, M. A., Bogte, H., & Swaab, D. F. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)80003-a · Cited by 63
Effects of estradiol on ischemic factor-induced astrocyte swelling and AQP4 protein abundance
Rutkowsky, J. M., Wallace, B. K., Wise, P. M., & O’Donnell, M. E. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00399.2010 · Cited by 60
CSF oxytocin and vasopressin levels after recovery from bulimia nervosa and anorexia nervosa, bulimic subtype
Frank, G., Kaye, W. H., Altemus, M. M., & Greeno, C. G. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00243-2 · Cited by 60
Increased Expression of Vasopressin V 1a Receptors after Traumatic Brain Injury
Szmydynger‐Chodobska, J., Chung, I., Koźniewska, E., Tran, B. G., Harrington, F. J., Duncan, J. A., & Chodobski, A. (2004) · Journal of Neurotrauma · doi:10.1089/0897715041651033 · Cited by 59
Vasopressin in Alzheimer's disease: A study of postmortem brain concentrations
Mazurek, M. F., Bed, M. F., Bird, E. D., & Martin, J. B. (1986) · Annals of Neurology · doi:10.1002/ana.410200603 · Cited by 59
Mitochondria, Oxytocin, and Vasopressin: Unfolding the Inflammatory Protein Response
Bordt, E. A., Smith, C. J., Demarest, T. G., Bilbo, S. D., & Kingsbury, M. A. (2019) · Neurotoxicity Research · doi:10.1007/s12640-018-9962-7 · Cited by 58
Hypoxia effects on cell volume and ion uptake of cerebral microvascular endothelial cells
Brillault, J., Lam, T. I., Rutkowsky, J. M., Foroutan, S., & O’Donnell, M. E. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00148.2007 · Cited by 60
Evaluation of the Secretory Pattern of Plasma Arginine Vasopressin in Stroke Patients
BARRECA, T., Gandolfo, C., Corsini, G. P., Sette, M. D., Cataldi, A., Rolandi, E., & FRANCESCHINI, R. (2001) · Cerebrovascular Diseases · doi:10.1159/000047622 · Cited by 58
Neuropeptides involved in the pathophysiology of schizophrenia and major depression
de Wied, D., & Sigling, H. O. (2002) · Neurotoxicity Research · doi:10.1080/10298420290031432 · Cited by 52
Evaluation of delayed treatment of focal cerebral ischemia with three selective kappa-opioid agonists in cats.
Baskin, D. S., Widmayer, M. A., Browning, J. L., Heizer, M. L., & Schmidt, W. K. (1994) · Stroke · doi:10.1161/01.str.25.10.2047 · Cited by 52
Structural studies of the hypothalamus and its nuclei in mood disorders
Schindler, S., Geyer, S., Strauß, M., Anwander, A., Hegerl, U., Turner, R., & Schönknecht, P. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.06.005 · Cited by 51
The cerebello-hypothalamic–pituitary–adrenal axis dysregulation hypothesis in depressive disorder
Schutter, D. J. L. G. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.08.027 · Cited by 47
Neuronal hypertrophy in the human supraoptic and paraventricular nucleus in aging and Alzheimer's disease
Vogels, O. J. M., Broere, C. A. J., & Nieuwenhuys, R. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90538-k · Cited by 45
Endocrine Studies in Patients With Pseudotumor Cerebri
Sørensen, P. S. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520090038013 · Cited by 44
Treatment of Brain Edema with a Nonpeptide Arginine Vasopressin V1 Receptor Antagonist OPC-21268 in Rats
Bemana, I., & Nagao, S. (1999) · Neurosurgery · doi:10.1097/00006123-199901000-00091 · Cited by 43
Chapter 16 The human hypothalamo-neurohypophyseal system in relation to development, aging and Alzheimer's disease
Goudsmit, E., Neijmeijer-Leloux, A., & Swaab, D. F. (1992) · Progress in brain research · doi:10.1016/s0079-6123(08)64575-6 · Cited by 41
Studies of vasopressin in the human cerebrospinal fluid
Sørensen, P. S. (1986) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1986.tb04633.x · Cited by 41
Neuropeptide and Sigma Receptors as Novel Therapeutic Targets for the Pharmacotherapy of Depression
Paschos, K. A., Veletza, S. V., & Chatzaki, Ε. (2009) · CNS Drugs · doi:10.2165/11310830-000000000-00000 · Cited by 36
Plasma arginine-vasopressin following experimental stroke: effect of osmotherapy
Chang, Y., Chen, T., Chen, C., Crain, B. J., Toung, T. J. K., & Bhardwaj, A. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00763.2005 · Cited by 35
Plasma and cerebrospinal fluid arginine vasopressin in patients with and without fever.
Sharples, P. M., Seckl, J. R., Human, D., Lightman, S. L., & Dunger, D. B. (1992) · Archives of Disease in Childhood · doi:10.1136/adc.67.8.998 · Cited by 34
Involvement of Neuropeptide Systems in Schizophrenia: Human Studies
Cáceda, R., Kinkead, B. L., & Nemeroff, C. B. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(06)78011-4 · Cited by 33
Microelectrode Biosensors for in vivo Analysis of Brain Interstitial Fluid
Chatard, C., Meiller, A., & Marinesco, S. (2018) · Electroanalysis · doi:10.1002/elan.201700836 · Cited by 34
Endocrine abnormalities and outcome of ischaemic stroke
FRANCESCHINI, R., Tenconi, G. L., Zoppoli, F., & BARRECA, T. (2001) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(01)00086-5 · Cited by 32
Multiple Sites of Vasopressin Synthesis in the Injured Brain
Szmydynger‐Chodobska, J., Zink, B. J., & Chodobski, A. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.188 · Cited by 30
Vasopressin Gene Expression in Rat Choroid Plexus
Chodobski, A., Wojcik, B. E., Loh, Y. P., Dodd, K. A., Szmydynger‐Chodobska, J., Johanson, C. E., Demers, D. M., Chun, Z. G., & Limthong, N. P. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4871-3_6 · Cited by 29
Hormonal Aspects of Fluid and Sodium Balance in the Elderly
Miller, M. (1995) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30040-9 · Cited by 29
Neuropeptide modulation of central vestibular circuits.
Balaban, C. D., Starcevic, V. P., & Severs, W. B. (1989) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00023-7 · Cited by 29
Chapter 8 Neuropeptides and dementia
Rossor, M. N., Emson, P. C., Dawbarn, D., Mountjoy, C. Q., & Roth, M. (1986) · Progress in brain research · doi:10.1016/s0079-6123(08)64603-8 · Cited by 29
Arginine Vasopressin V 1a Receptor-Deficient Mice Have Reduced Brain Edema and Secondary Brain Damage following Traumatic Brain Injury
Rauen, K., Trabold, R., Brem, C., Terpolilli, N. A., & Plesnila, N. (2013) · Journal of Neurotrauma · doi:10.1089/neu.2012.2807 · Cited by 30
The Role of the Blood-Brain Barrier Na-K-2Cl Cotransporter in Stroke
O’Donnell, M. E., Lam, T. I., Tran, L., & Anderson, S. E. (2006) · Springer eBooks · doi:10.1007/0-387-23752-6_6 · Cited by 27
Stimulation of the pituitary-adrenal axis with a low dose [Arg8]-vasopressin in depressed patients and healthy subjects
Wied, C. C. G., Westenberg, H. G. M., Koppeschaar, H. P. F., Thijssen, J. H. H., & van Ree, J. M. (1992) · European Neuropsychopharmacology · doi:10.1016/0924-977x(92)90003-q · Cited by 27
Arginine Vasopressin Receptor Antagonists for Treatment of Vasogenic Brain Edema: An Experimental Study
Kagawa, M., Nagao, S., & Bemana, I. (1996) · Journal of Neurotrauma · doi:10.1089/neu.1996.13.273 · Cited by 27
Fear and power-dominance motivation: proposed contributions of peptide hormones present in cerebrospinal fluid and plasma
Sewards, T. V., & Sewards, M. A. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00034-4 · Cited by 26
AVP- and OT-neurophysins response to apomorphine and clonidine in major depression
Scantamburlo, G., Hansenne, M., Fuchs, S., Pitchot, W., Pinto, E., Reggers, J., Ansseau, M., & Legros, J. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.04.015 · Cited by 26
Neuropeptides and Alzheimer's disease
Gottfries, C., Frederiksen, S. O., & Heilig, M. (1995) · European Neuropsychopharmacology · doi:10.1016/0924-977x(95)80009-q · Cited by 26
Cerebrospinal fluid neurohypophysial peptides in benign intracranial hypertension.
Seckl, J. R., & Lightman, S. L. (1988) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.12.1538 · Cited by 24
Neurohypophysial Peptides in Cerebrospinal Fluid: An Update
Robinson, I. C. A. F., & Coombes, J. E. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb55553.x · Cited by 24
Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: A randomized, double-blind, placebo-controlled, clinical trial
Hosseini, S. M. R., Farokhnia, M., Rezaei, F., Gougol, A., Yekehtaz, H., Iranpour, N., Salehi, B., Tabrizi, M. H., Tajdini, M., Ghaleiha, A., et al. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.02.001 · Cited by 23
Baseline studies on transmitter substances in cerebrospinal fluid in depression
Gjerris, A. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb10571.x · Cited by 22
Self-citation
Arginine vasopressin release inhibitor RU51599 attenuates brian oedema following transient forebrain ischaemia in rats
Ikeda, Y., Toda, S., Kawamoto, T., & Teramoto, A. (1997) · Acta Neurochirurgica · doi:10.1007/bf01410978 · Cited by 22
Alterations in Neuropeptides in Aging and Disease
Leake, A., & Ferrier, I. N. (1993) · Drugs & Aging · doi:10.2165/00002512-199303050-00003 · Cited by 21
An evaluation of human neurophysin production in Alzheimer's disease: Preliminary observations
North, W. G., Harbaugh, R. E., & Reeder, T. M. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90038-y · Cited by 20
Cerebrospinal Fluid Markers of Alzheimer's Disease
van Gool, W. A., & Bolhuis, P. A. (1991) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1991.tb04052.x · Cited by 20
Biochemical profile of human infant cerebrospinal fluid in intraventricular hemorrhage and post-hemorrhagic hydrocephalus of prematurity
Otun, A., Morales, D. M., García‐Bonilla, M., Goldberg, S., Castañeyra-Ruiz, L., Yan, Y., Isaacs, A. M., Strahle, J. M., McAllister, J. P., & Limbrick, D. D. (2021) · Fluids and Barriers of the CNS · doi:10.1186/s12987-021-00295-8 · Cited by 18
Ion and Water Transport across the Blood–Brain Barrier
O’Donnell, M. E. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374373-2.00030-3 · Cited by 17
Vasopressin levels in CSF of Alzheimer patients: Correlations with monoamine metabolites and neuropsychological test performance
Jolkkonen, J., Helkala, E.-L., Kutvonen, R., Lehtinen, M., & Riekkinen, P. J. (1989) · Psychoneuroendocrinology · doi:10.1016/0306-4530(89)90057-7 · Cited by 16
Plasma copeptin and metabolic dysfunction in individuals with bipolar disorder
Mansur, R. B., Rizzo, L. B., Santos, C. M., Asevedo, E. D. M., da Cunha, G. R., Noto, M. N., Pedrini, M., Zeni‐Graiff, M., Cordeiro, Q., McIntyre, R. S., et al. (2017) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12535 · Cited by 15
Treatment of Vasogenic Brain Edema with Arginine Vasopressin Receptor Antagonist — an Experimental Study
Nagao, S., Kagawa, M., Bemana, I., Kuniyoshi, T., Ogawa, T., Honma, Y., & Kuyama, H. (1994) · Springer eBooks · doi:10.1007/978-3-7091-9334-1_137 · Cited by 15
Association between bipolar episodes and fluid and electrolyte homeostasis: a retrospective longitudinal study
Hochman, E., Weizman, A., Valevski, A., Fischel, T., & Krivoy, A. (2014) · Bipolar Disorders · doi:10.1111/bdi.12248 · Cited by 14
Vasopressin V 1a Receptors Regulate Cerebral Aquaporin 1 after Traumatic Brain Injury
Rauen, K., Pop, V., Trabold, R., Badaut, J., & Plesnila, N. (2019) · Journal of Neurotrauma · doi:10.1089/neu.2019.6653 · Cited by 14
Peripheral measures of arginine vasopressin, atrial natriuretic peptide and adrenocorticotropic hormone in premenstrual syndrome
Rosenstein, D. L., Kalogeras, K. T., Kalafut, M. A., Malley, J. D., & Rubinow, D. R. (1996) · Psychoneuroendocrinology · doi:10.1016/0306-4530(95)00035-6 · Cited by 14
Plasmatic vasopressin neurophysin in depression: Basic levels and relations with HPA axis
Laruelle, M. A., Seghers, A., Goffinet, S., Bouchez, S., & Legros, J. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90423-y · Cited by 14
Recent Developments in Gerontopsychiatric Research on Age-Associated Dementia in Japan
Homma, A., & Hasegawa, K. (1989) · International Psychogeriatrics · doi:10.1017/s1041610289000049 · Cited by 13
Vasopressin and vasopressin analogues for treatment of memory disorders in clinical practice
Lecros, J.-J., & Timsit-Berthier, M. (1988) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(88)90074-7 · Cited by 13
Vasopressin-neurophysin and bipolar depression
Legros, J., & Ansseau, M. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90226-x · Cited by 12
Syndrome of inappropriate secretion of antidiuretic hormone associated with schizophrenia
Suzuki, M., Takeuchi, O., Mori, I., Takegoshi, K., & Kurachi, M. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90098-k · Cited by 12
Antidiuretic hormone release associated with increased intracranial pressure independent of plasma osmolality
Keller, W. J., & Mullaj, E. (2018) · Brain and Behavior · doi:10.1002/brb3.1005 · Cited by 11
Intracerebroventricular arginine vasopressin causes intracranial pressure to rise in conscious goats
Seckl, J. R., & Lightman, S. L. (1987) · Brain Research · doi:10.1016/0006-8993(87)90850-x · Cited by 11
Electroencephalographic and early communicative abnormalities in Brattleboro rats
Lin, R. E., Ambler, L., Billingslea, E. N., Suh, J., Batheja, S., Tatard-Leitman, V. M., Featherstone, R. E., & Siegel, S. J. (2013) · Physiological Reports · doi:10.1002/phy2.100 · Cited by 11
Intracerebroventricular vasopressin reduces CSF absorption rate in the conscious goat
Seckl, J. R., & Lightman, S. L. (1991) · Experimental Brain Research · doi:10.1007/bf00231772 · Cited by 11
Attenuation of cryogenic induced brain oedema by arginine vasopressin release inhibitor RU51599
Ikeda, Y., Teramoto, A., Nakagawa, Y., Ishibashi, Y., & Yoshii, T. (1997) · Acta Neurochirurgica · doi:10.1007/bf01410979 · Cited by 11
Increased intracranial pressure is associated with elevated cerebrospinal fluid ADH levels in closed-head injury
Widmayer, M. A., Browning, J. L., Gopinath, S. P., Robertson, C. S., & Baskin, D. S. (2010) · Neurological Research · doi:10.1179/016164110x12714125204155 · Cited by 8
The Role of the Choroid Plexus in the Transport and Production of Polypeptides
Silverberg, G. D., Szmydynger‐Chodobska, J., & Chodobski, A. (2005) · CRC Press eBooks · doi:10.1201/9781420023404.ch10 · Cited by 8
Neuropeptides of the human magnocellular hypothalamus
Pałasz, A., Vecchia, A. D., Saganiak, K., & Worthington, J. J. (2021) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2021.102003 · Cited by 7
The clinical manifestation and treatment of Meniere's Disease from the viewpoint of the water homeostasis of the inner ear
Takeda, T., Takeda, S., & Kakigi, A. (2024) · Auris Nasus Larynx · doi:10.1016/j.anl.2024.08.002 · Cited by 7
Neuropeptidases
Hui, K. S. (2007) · Springer eBooks · doi:10.1007/978-0-387-30379-6_21 · Cited by 7
Increase in vasopressin binding sites in the human choroid plexus in Alzheimer's disease
Korting, C., van Zwieten, E. J., Boer, G. J., Ravid, R., & Swaab, D. F. (1996) · Brain Research · doi:10.1016/0006-8993(95)01242-7 · Cited by 7
Manic–depression neural conduction speeds and action potential event dyscorrelation
Newton, J. R. (1999) · Medical Hypotheses · doi:10.1054/mehy.1997.0610 · Cited by 7
Neuropeptides in Alzheimer's Disease: Clinical implications
Mazurek, M. F., Beal, M. F., & Martin, J. B. (1986) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30946-0 · Cited by 7
Corticosterone oscillations during mania induction in the lateral hypothalamic kindled rat—Experimental observations and mathematical modeling
Abulseoud, O. A., Ho, A. M., Choi, D., Stanojević, A., Čupić, Ž., Kolar-Anic, L. Z., & Vukojević, V. B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177551 · Cited by 5
Neurohormones in Depression and Anxiety
Altemus, M. M., & Gold, P. W. (1993) · Elsevier eBooks · doi:10.1016/b978-0-12-631330-7.50017-4 · Cited by 5
Dementias (Alzheimer's and Pick's Disease): Dysfunctional and Structural Changes
STIGSBY, B. (1988) · American Journal of EEG Technology · doi:10.1080/00029238.1988.11080251 · Cited by 3
Therapeutic potential of vasopressin in the treatment of neurological disorders
Mishra, S., Grewal, J., Wal, P., Bhivshet, G. U., Tripathi, A. K., & Walia, V. (2024) · Peptides · doi:10.1016/j.peptides.2024.171166 · Cited by 2
Experimental Therapies for Brain Edema and Intracranial Hypertension
Rauen, K., & Plesnila, N. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803196-4.00019-9 · Cited by 2
Blood-Brain Barrier Mechanisms of Edema Formation
O’Donnell, M. E., Wulff, H., & Chen, Y. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803196-4.00007-2 · Cited by 2
Effect of Niravoline (RU51599), a κ-Opioid Receptor Agonist, on Tumour-Origin Brain Oedema
Takahashi, H., Hamada, H., & Teramoto, A. (1999) · Acta Neurochirurgica · doi:10.1007/s007010050374 · Cited by 1
Dementia and neuropeptides
Gottfries, C. G. (1991) · European Neuropsychopharmacology · doi:10.1016/0924-977x(91)90583-g · Cited by 1
Changes of the Neuroendocrine System in Alzheimer-type Dementia
Kiuchi, Y., Parvez, H. S., Parvez, S., & Yasuhara, H. (1992) · doi:10.1007/978-1-349-12275-2_7 · Cited by 1
Effect of Cerebroventricular Infusion of Vasopressin on Intracranial Pressure, Blood Pressure and Plasma Vasopressin
Sørensen, P. S., & Gyring, J. (1986) · Springer eBooks · doi:10.1007/978-3-642-70971-5_95 · Cited by 1
Impaired repression at a vasopressin promoter polymorphism in a rat model of trait anxiety and depression
Murgatroyd, C. (2005) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.3592
Biocapteurs implantables pour un monitorage intracérébral minimalement invasif
Chatard, C. (2018) · theses.fr (ABES) · doi:10.70675/1880b7a0z30d6z4a12za2b9za72ac2b0053b

Authors: Sorensen, P. S., Gjerris, A., & Hammer, M.
Venue: Journal of Neurology, Neurosurgery & Psychiatry
Publisher: BMJ
Published: 1985-01-01
Volume: 48
Issue: 1
Pages: 50-57
ISSN: 0022-3050 (ISSN-L)
DOI: 10.1136/jnnp.48.1.50
PMC: PMC1028182
OpenAlex: W2048921697
Cited by: 103
References: 46
Citations by year: 2026: 2 · 2024: 2 · 2021: 2 · 2019: 1 · 2018: 4 · 2017: 4 · 2016: 1 · 2014: 5 · 2013: 2 · 2012: 2
FWCI: 8.55
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Journal of Neurology Neurosurgery & Psychiatry (publishedVersion)
PubMed Central (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed (publishedVersion)
HighWire Press Open Archive (submittedVersion)
Topics: Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
Keywords: vasopressin, cerebrospinal fluid, plasma vasopressin, intracranial tumors, idiopathic intracranial hypertension, intracranial hemorrhage, ischemic stroke, traumatic brain injury, degenerative dementia, mania, depression, recovery from depression
MeSH terms: Adult, Aged, Arginine Vasopressin, Basal Ganglia Diseases, Mental Disorders, Bipolar Disorder, Brain Diseases, Brain Neoplasms, Cerebral Hemorrhage, Cerebral Infarction, Dementia, Depressive Disorder, Female, Humans, Hydrocephalus, Hydrocephalus, Normal Pressure, Intracranial Pressure, Male, Middle Aged, Multiple Sclerosis, Pseudotumor Cerebri, Schizophrenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cerebrospinal-fluid vasopressin in neurological and psychiatric-disorders

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks